Estradiol butyrate benzoate
Clinical data | |
---|---|
Routes of administration | Intramuscular |
Identifiers | |
| |
CAS Number | 63042-18-2 |
PubChem (CID) | 67081 |
ChemSpider | 60431 |
Chemical and physical data | |
Formula | C29H34O4 |
Molar mass | 446.57786 g/mol |
3D model (Jmol) | Interactive image |
| |
|
Estradiol butyrate benzoate, or estradiol 3-benzoate 17β-n-butyrate, also known as estra-1,3,5(10)-triene-3,17β-diol 3-benzoate 17β-n-butyrate, is a semisynthetic, steroidal estrogen and an estrogen ester – specifically, the 3-benzoate 17β-n-butyrate diester of estradiol – which was never marketed.[1][2] Under the tentative brand name Unimens, estradiol butyrate benzoate was studied in combination with the progestogen algestone acetophenide (dihydroxyprogesterone acetophenide) as a once-monthly combined injectable contraceptive (at doses of 10 mg and 150 mg, respectively).[1][2][3]
See also
References
- 1 2 Toppozada M (1977). "The clinical use of monthly injectable contraceptive preparations". Obstet Gynecol Surv. 32 (6): 335–47. PMID 865726.
- 1 2 Mokhtar K. Toppozada (1983), Monthly Injectable Contraceptives (PDF)
- ↑ Elsayed Saad Eldin Hafez (1980). Human reproduction: conception and contraception. Harper and Row. ISBN 978-0-06-141066-6.
This article is issued from Wikipedia - version of the 11/22/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.